Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Certain bonds and fund structures minimize tax impact, making them attractive for retirees seeking reliable after-tax income.
22,436 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Freddie Mac data show mortgage rates climbed to their highest level in almost four months, pushing the 30-year loan t...
Sunoco LP is redefining its business, shifting from fueling pumps to a broader energy platform. With 2026 EBITDA guid...
Analysts see SpaceX, OpenAI, and Anthropic pursuing record mega-IPOs in 2026, potentially reshaping liquidity for ven...
A Seattle federal judge denied Northwest MLS's bid to dismiss Compass’s antitrust lawsuit, keeping the Compass case o...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Despite higher mortgage costs, housing demand still growing remains intact. Weekly data show ongoing buyer interest e...
Amazon is pursuing a colossal 2026 investment plan centered on AI and cloud tech. This guide breaks down the risks, p...
Cardano's ADA is set for a major upgrade while traders watch a tight price range. Regulatory clarity and cross-chain ...
Geopolitical tensions between the U.S. and Iran are dominating crypto moves, with Bitcoin and XRP trading in tight ra...